Scpharmaceuticals

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082427  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082434  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082460  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950170-25-097218  Act: 34  Size: 9 KB 网页链接

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082425  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-25-186947  Act: 34  Size: 166 KB 网页链接

$Scpharmaceuticals(SCPH)$ SC14D9C Written communication relating to third party tender offer Accession Number: 0001193125-25-187698  Act: 34  Size: 148 KB 网页链接

$Scpharmaceuticals(SCPH)$ 8-K Current report, item 5.07 Accession Number: 0001193125-25-137863  Act: 34  Size: 145 KB 网页链接

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082426  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082436  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082541  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-175411  Act: 34  Size: 210 KB 网页链接

约合3.6亿美金代价，M&A。递送系统+呋塞米。
8月25日，MannKind（Nasdaq:MNKD）和scPharmaceuticals（Nasdaq:SCPH）宣布签署最终合并协议。$曼恩凯德生物医疗(MNKD)$ #Seeking# #biotech#

$Scpharmaceuticals(SCPH)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001193125-25-187714  Act: 34  Size: 73 KB 网页链接

$Scpharmaceuticals(SCPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-082429  Size: 5 KB 网页链接

$Scpharmaceuticals(SCPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-175437  Act: 34  Size: 9 MB 网页链接

$Scpharmaceuticals(SCPH)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001193125-25-186993  Act: 34  Size: 1 MB 网页链接

$Scpharmaceuticals(SCPH)$ SC14D9C Written communication relating to third party tender offer Accession Number: 0001193125-25-186996  Act: 34  Size: 9 KB 网页链接

$Scpharmaceuticals(SCPH)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001193125-25-187082  Act: 34  Size: 70 KB 网页链接